Teva Pharmaceutical is a leading pharmaceutical company established in Jerusalem in 1901. The company is known today as Teva starts out as a small wholesale drug business that distributes imported medications. It was founded by Chaim Salomon, Moshe Levin, and Yitschak Elstein.

In 2010, the company has acquired German Ratiopharm that increases Teva’s market share in Europe. The company has harness ratiopharm’s excellent foundation for biosimilars, branded generics, and tenders. It became the world’s largest medicine cabinet since Teva Pharmaceutical provides medicines to 200 million people around the world every day.

The company has one of the most competitive operational networks in the industry, with sales in approximately 100 global markets and a portfolio of 16,000 products, spanning generics, specialty, and OTC. In the eve of 2011, the leading company has acquired Theramex, European-based women’s health business, that brings the company as a broad Women’s Health and gynecology portfolio, and a unique innovative pipeline.

Teva Pharmaceutical delivers solutions in key therapeutic areas of Central Nervous System, Pain, Respiratory, and Oncology. It has a portfolio of over 1,000 generic molecules that provides treatment options more affordable and accessible to needy people and healthcare providers.

The acquisition strongly reinforces the strategy of the company accelerated the creation of its new business model and opens a new set of responsibilities as well as active functioning. This strategic move nourishes the company to improve capabilities and flexibility in order to provide access to more people throughout the world.